Tag: Spyre Therapeutics

Spyre Therapeutics Announces Grants of Inducement Awards

WALTHAM, Mass., June 6, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering,...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsSpyre Therapeutics

Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering

GENISOM AI Debuts at ICRA 2026 with Full-Stack Embodied Intelligence System

Harbour BioMed Announces NMPA Acceptance of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors

Tag: Spyre Therapeutics

Spyre Therapeutics Announces Grants of Inducement Awards

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us